“Our patients deserve better”—roadblocks to optimal care in biliary malignancies
ESMO Open · 2026-11 · 11 (11) · 108596
DOI: 10.1016/j.esmoop.2026.108596 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Open, 2026-11. Verfasst von A Lamarca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, OECI Comprehensive Cancer Centre with Research Excellence - ENETS Centre of Excellence (GEP and Lung) - Fundacion Jim…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS.
Abstract (Originalsprache)
Biliary tract cancers (BTCs) are associated with poor outcomes, with many patients never receiving any cancer-directed treatment. Population-based registries from England, France, Italy and Spain share a similar picture: emergency presentation, rather than planned referral, accounts for roughly half of diagnoses, and >50% of patients with cholangiocarcinoma in England received neither surgery, systemic therapy nor stenting. This attrition is not exclusive to real-world settings: in PROOF-301 and FIGHT-302, a considerable proportion of eligible or randomly assigned patients never started their allocated treatment. BTC is also no longer a disease confined to older adults, with ∼7% of cases diagnosed in individuals
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, OECI Comprehensive Cancer Centre with Research Excellence - ENETS Centre of Excellence (GEP and Lung) - Fundacion Jimenez Diaz University Hospital, Health Research Institute Fundación Jim…
- Department of Medical Oncology, Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Translational Oncology in Upper Gastrointestinal Cancer Group, Institut d'Investigacions Biomèdiques August Pi…
- Medical Oncology Department, University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Hepatobiliary Immunopathology Lab, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Hepatopancreatobiliary Oncology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- Department of Medical Oncology, UCL Cancer Institute, London, UK.
Förderung
- Fondazione AIRC per la ricerca sul cancro ETS
Zitieren
APA
Lamarca, A., Macias, I., Crespo Cruz, M. I., Cammarota, A., Rimassa, L., & Bridgewater, J. (2026). “Our patients deserve better”—roadblocks to optimal care in biliary malignancies. ESMO Open, 11(11), 108596. https://doi.org/10.1016/j.esmoop.2026.108596
Vancouver
Lamarca A, Macias I, Crespo Cruz MI, Cammarota A, Rimassa L, Bridgewater J. “Our patients deserve better”—roadblocks to optimal care in biliary malignancies. ESMO Open. 2026;11(11):108596. doi:10.1016/j.esmoop.2026.108596
BibTeX
@article{Lamarca2026,
author = {Lamarca, A and Macias, I and Crespo Cruz, M I and Cammarota, A and Rimassa, L and Bridgewater, J},
title = {“Our patients deserve better”—roadblocks to optimal care in biliary malignancies},
journal = {ESMO Open},
year = {2026},
volume = {11},
number = {11},
pages = {108596},
doi = {10.1016/j.esmoop.2026.108596}
}
EUVIMED